We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$299M
AUM Growth
+$24M
(+8.7%)
Cap. Flow
+$15.5M
Cap. Flow
% of AUM
5.19%
Top 10 Holdings %
Top 10 Hldgs %
25.13%
Holding
114
New
14
Increased
54
Reduced
38
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eaton
ETN
|
+$6.18M |
| 2 |
KLA
KLAC
|
+$6.08M |
| 3 |
Huntington Bancshares
HBAN
|
+$6.06M |
| 4 |
Darden Restaurants
DRI
|
+$3.78M |
| 5 |
Qualcomm
QCOM
|
+$2.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$5.14M |
| 2 |
UFS
DOMTAR CORPORATION (New)
UFS
|
+$3.43M |
| 3 |
AbbVie
ABBV
|
+$3.42M |
| 4 |
MetLife
MET
|
+$734K |
| 5 |
UnitedHealth
UNH
|
+$542K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.19% |
| 2 | Healthcare | 15.18% |
| 3 | Technology | 15.01% |
| 4 | Consumer Discretionary | 12.77% |
| 5 | Industrials | 11.81% |
Similar funds
MWM
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
Palouse Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Palouse Capital Management held 114 positions worth $299M, up 8.7% from $275M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Palouse Capital Management deployed $15.5M of net new capital in Q3 2017, opening 14 new positions and adding to 54 existing holdings. Its largest new stake was Eaton: 81,902 shares worth $6.29M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was AbbVie, an estimated $3.42M trimmed.
- Palouse Capital Management's largest Q3 2017 buy was Eaton: 81,902 shares worth $6.29M.
- Palouse Capital Management added most to Walgreens Boots Alliance in Q3 2017, an estimated $2.24M increase.
- Palouse Capital Management's biggest Q3 2017 reduction was AbbVie, cutting an estimated $3.42M.
- Palouse Capital Management fully exited Elevance Health in Q3 2017, selling an estimated $5.14M.
- Palouse Capital Management's ten largest holdings make up 25% of its $299M portfolio in Q3 2017.
- Palouse Capital Management opened 14 new positions and closed 6 in Q3 2017.
- Palouse Capital Management's portfolio value rose 8.7% quarter-over-quarter to $299M.
Based on Palouse Capital Management's 13F filing for Q3 2017, filed 30 Oct 2017.